Forte Biosciences, Inc. Profile Avatar - Palmy Investing

Forte Biosciences, Inc.

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas,…

Biotechnology
US, Dallas [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Forte Biosciences, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Forte Biosciences, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Forte Biosciences, Inc..

End of FBRX's Analysis
CIK: 1419041 CUSIP: 34962G109 ISIN: US34962G1094 LEI: - UEI: -
Secondary Listings
FBRX has no secondary listings inside our databases.